Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-19T15:23:25.479Z Has data issue: false hasContentIssue false

Double-blind study of the addition of high-protein soya milk v. cows' milk to the diet of patients with severe hypercholesterolaemia and resistance to or intolerance of statins

Published online by Cambridge University Press:  09 March 2007

C. R. Sirtori*
Affiliation:
Center E. Grossi Paoletti, Institute of Pharmacological Sciences, University of Milan, Italy
F. Pazzucconi
Affiliation:
Center E. Grossi Paoletti, Institute of Pharmacological Sciences, University of Milan, Italy
L. Colombo
Affiliation:
S. Paolo Hospital, Milan, Italy
P. Battistin
Affiliation:
Center E. Grossi Paoletti, Institute of Pharmacological Sciences, University of Milan, Italy
A. Bondioli
Affiliation:
Center E. Grossi Paoletti, Institute of Pharmacological Sciences, University of Milan, Italy
K. Descheemaeker
Affiliation:
Alpro N.V., Wevelgem, Belgium
*
*Corresponding author: Professor Cesare Sirtori, fax +39 02 29 404 961, email cesare.sirtori@unimi.it
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Total substitution of soyabean protein for animal protein in the diet has been repeatedly shown to lower plasma cholesterol levels in hypercholesterolaemic individuals. A new, highly palatable, high-protein soya drink may allow replacement of a significant percentage of animal protein in the diet. The soya drink was given, within a crossover design v. a cows' milk preparation of similar composition and taste, to twenty-one severely hypercholesterolaemic patients (mean baseline plasma cholesterol 8·74 mmol/l) with a history of resistance to or intolerance of statin treatment. Each dietary supplement was given for 4 weeks, with a 4-week interval between treatments, Plasma lipid levels were monitored every 2 weeks during each dietary sequence. The concomitant dietary treatment, which had been followed for a long time by all patients, was carefully monitored throughout the study. The soya supplementation reduced plasma total cholesterol level by 6·5%, when given first, and by 7·4% when given after cows' milk. When given first, cows' milk resulted in a small, non-significant reduction of plasma cholesterol level (-3·9%), and when given after soya, it changed total plasma cholesterol to a minimal extent (-1·6%). Changes in total and LDL-cholesterol levels after 2 and 4 weeks of soya v. cows' milk treatment were, thus, respectively -6·1, -7·0 and -6·2, -7·8% (both P < 0·05). These first data from a double-blind study confirm a significant cholesterol-lowering effect of soyabean protein, even when only partly replacing animal protein in the diet, in individuals with extreme plasma cholesterol elevations.

Type
Research Article
Copyright
Copyright © The Nutrition Society 1999

References

Anderson, JW, Johnstone, BJ & Cook-Newell, ME (1995) Meta-analysis of the effects of soy protein intake on serum lipids. New England Journal of Medicine 333, 276282.CrossRefGoogle ScholarPubMed
Anderson, JW, Story, L, Sieling, B, Lin Chen, W-J, Petro, MS & Story, J (1984) Hypocholesterolemic effects of oat-bran or bean intake for hypercholesterolemic men. American Journal of Clinical Nutrition 40, 11461155.CrossRefGoogle ScholarPubMed
Anthony, MS, Clarkson, TB, Hughes, CL, Morgan, TM & Burke, GL (1996) Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of prepubertal rhesus monkeys. Journal of Nutrition 126, 4350.CrossRefGoogle Scholar
Bakhit, RM, Klein, BP, Essex-Sorlie, D, Ham, JO, Erdman, JW Jr & Potter, SM (1994) Intake of 25 g of soybean protein with or without soybean fiber alters plasma lipids in men with elevated cholesterol concentrations. Journal of Nutrition 124, 213222.CrossRefGoogle ScholarPubMed
Calvert, GD, Blight, L, Illman, RJ, Topping, DL & Potter, JD (1981) A trial of the effects of soya-bean flour and soya-bean saponins on plasma lipids, faecal bile acids and neutral sterols in hypercholesterolaemic men. British Journal of Nutrition 45, 277281.CrossRefGoogle ScholarPubMed
Carroll, KK (1991) Review of clinical studies on cholesterol-lowering response to soy protein. Journal of the American Dietetic Association 91, 820827.CrossRefGoogle ScholarPubMed
Cassidy, A, Bingham, S & Setchell, KDR (1994) Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. American Journal of Clinical Nutrition 60, 333340.CrossRefGoogle Scholar
Finkel, E (1998) Phyto-oestrogens: the way to postmenopausal health? (editorial). Lancet 352, 1762.CrossRefGoogle Scholar
Friedewald, WT, Levy, RI & Fredrickson, DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 18, 499502.CrossRefGoogle ScholarPubMed
Frühbeck, G, Monreal, I & Santidrian, S (1997) Hormonal implications of the hypocholesterolemic effects of field beans (Vicia faba L.) by young men with hypercholesterolemia. American Journal of Clinical Nutrition 66, 14521460.CrossRefGoogle ScholarPubMed
Fumagalli, R, Soleri, L, Musanti, R, Mantero, O, Noseda, C, Gatti, E & Sirtori, CR (1982) Fecal cholesterol excretion studies in type II hypercholesterolemic patients treated with the soybean protein diet. Atherosclerosis 43, 341353.CrossRefGoogle ScholarPubMed
Giroux, I, Lavigne, C, Moorjani, S & Jacques, H (1997) Simvastatin further enhances the hypocholesterolemic effect of soy protein in rabbits. Journal of the American College of Nutrition 16, 166174.CrossRefGoogle ScholarPubMed
Grove, RI, Mazzucco, CR, Radka, SF, Shoyab, M & Kiener, PA (1991) Oncostatin M up-regulates low density lipoprotein receptors in HepG2 cells by a novel mechanism. Journal of Biological Chemistry 266, 1819418199.CrossRefGoogle ScholarPubMed
Hodgson, JM, Pudey, IB, Beilin, LJ, Mori, TA & Croft, KD (1998) Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. Journal of Nutrition 128, 728732.CrossRefGoogle Scholar
Kurowska, EM, Jordan, J, Spence, JD, Wetmore, S, Piché, LA, Radzikowski, M, Dandona, P & Carroll, KK (1997) Effects of substituting dietary soybean protein and oil for milk protein and fat in subjects with hypercholesterolemia. Clinical Investigation in Medicine 20, 162170.Google ScholarPubMed
Ladas, SD, Katsiyiannaki-Latoufi, E & Raptis, SA (1991) Lactose maldigestion and milk intolerance in healthy Greek schoolchildren. American Journal of Clinical Nutrition 53, 676680.CrossRefGoogle ScholarPubMed
Lopez-Miranda, J, Ordovas, JM, Mata, P, Lichtenstein, AH, Clevidence, B, Judd, JT & Schaefer, EJ (1994) Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. Journal of Lipid Research 35, 19651975.CrossRefGoogle ScholarPubMed
Lovati, MR, Manzoni, C, Canavesi, A, Sirtori, M, Vaccarino, V, Marchi, M, Gaddi, G & Sirtori, CR (1987) Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients. Journal of Clinical Investigation 80, 125130.CrossRefGoogle ScholarPubMed
Nestel, PJ, Yamashita, T, Sasahara, T, Pomeroy, S, Dart, A, Komesaroff, P, Owen, A & Abbey, M (1997) Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arteriosclerosis Thrombosis and Vascular Biology 17, 33923398.CrossRefGoogle Scholar
Ni, W, Tsuda, Y, Sakono, M & Imaizumi, K (1998) Dietary soy protein isolate, compared with casein, reduces atherosclerotic lesion area in apolipoprotein E-deficient mice. Journal of Nutrition 128, 18841889.CrossRefGoogle ScholarPubMed
Noseda, G, Fragiacomo, C, Gatti, E, Descovich, GC & Sirtori, CR (1982) Glucagon release following experimental diets in man: effects of soybean and casein enriched diets. Pharmacological Research Communications 257, 867877.CrossRefGoogle Scholar
Pazzucconi, F, Dorigotti, F, Gianfranceschi, G, Campagnoli, G, Sirtori, M, Franceschini, G & Sirtori, CR (1995) Therapy with HMG CoA reductase inhibitors: characteristics of the long-term permanence of hypocholesterolemic activity. Atherosclerosis 117, 189198.CrossRefGoogle ScholarPubMed
Potter, SM (1998) Soy protein and cardiovascular disease: the impact of bioactive components in soy. Nutrition Reviews 56, 231235.CrossRefGoogle ScholarPubMed
Rubinstein, A & Weintraub, M (1995) Escape phenomenon of low-density lipoprotein cholesterol during lovastatin treatment. American Journal of Cardiology 76, 184186.CrossRefGoogle ScholarPubMed
Simons, LA, Nestel, PJ, Clifton, P, Janus, ED, Simons, J & Parfitt, A (1992) Treatment of primary hypercholesterolaemia with pravastatin: efficacy and safety over three years. Medical Journal of Australia 157, 584589.CrossRefGoogle ScholarPubMed
Sirtori, CR (1993) Tissue selectivity of hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitors. Pharmacology and Therapeutics 60, 431459.CrossRefGoogle ScholarPubMed
Sirtori, CR, Agradi, E, Sirtori, M, Conti, F & Paoletti, R (1977) Soybean-protein diet in the treatment of type II hyperlipoproteinaemia. Lancet i, 275278.CrossRefGoogle Scholar
Sirtori, CR, Gatti, E, Mantero, O, Conti, F, Agradi, E, Tremoli, E, Sirtori, M, Fraterrigo, L, Tavazzi, L & Kritchevsky, D (1979) Clinical experience with the soybean protein diet in the treatment of hypercholesterolemia. American Journal of Clinical Nutrition 32, 16451658.CrossRefGoogle ScholarPubMed
Sirtori, CR, Gianazza, E, Manzoni, C, Lovati, MR & Murphy, PA (1997) Role of isoflavones in the cholesterol reduction by soy proteins in the clinic. American Journal of Clinical Nutrition 65, 166167.CrossRefGoogle ScholarPubMed
Sirtori, CR, Lovati, MR, Manzoni, C, Gianazza, E, Bondioli, A, Staels, B & Auwerx, J (1999) Reduction of serum cholesterol by soy proteins. Nutrition Metabolism Cardiovascular Disease 8, 334340.Google Scholar
Sirtori, CR, Lovati, MR, Manzoni, C, Monetti, M, Pazzucconi, F & Gatti, E (1995) Soy and cholesterol reduction: clinical experience. Journal of Nutrition 125, 598S605S.Google ScholarPubMed
Sirtori, CR, Tremoli, E, Gatti, E, Montanari, G, Sirtori, M, Colli, S, Gianfranceschi, G, Maderna, P, Zucchi, Dentone C, Testolin, G & Galli, C (1986) Controlled evaluation of fat intake in the Mediterranean diet: comparative activities of olive oil and corn oil on plasma lipids and platelets in high-risk patients. American Journal of Clinical Nutrition 44, 635642.CrossRefGoogle ScholarPubMed
Tovar-Palacios, C, Potter, SM, Hafermann, JC & Shay, NF (1998) Intake of soy protein and soy protein extracts influences lipid metabolism and hepatic gene expression in gerbils. Journal of Nutrition 128, 839842.CrossRefGoogle Scholar
Wallenstein, S & Fisher, AC (1977) The analysis of the two-period repeated measurements cross-over design with application to clinical trials. Biometrics 33, 261269.CrossRefGoogle Scholar
Warnick, GR, Benderson, J & Albers, JJ (1982) Dextran sulphate-Mg2+ precipitation procedure for quantitation of high-density lipoprotein. Clinical Chemistry 28, 13791388.CrossRefGoogle Scholar
Wilson, TA, Behr, SR & Nicolosi, RJ (1998) Addition of guar gum and soy protein increases the efficacy of the American Heart Association (AHA) step I cholesterol-lowering diet without reducing high density lipoprotein cholesterol levels in non-human primates. Journal of Nutrition 128, 14291433.CrossRefGoogle ScholarPubMed